PixarBio (PixarBio) Other Long-Term Liabilities : $0.00 Mil (As of Sep. 2016)

View and export this data going back to 2016. Start your Free Trial

What is PixarBio Other Long-Term Liabilities?

PixarBio's other long-term liabilities for the quarter that ended in Sep. 2016 was $0.00 Mil.

PixarBio's annual other long-term liabilities stayed the same from . 20 ($0.00 Mil) to Dec. 2014 ($0.00 Mil) but then increased from Dec. 2014 ($0.00 Mil) to Dec. 2015 ($0.00 Mil).

PixarBio Other Long-Term Liabilities Historical Data

The historical data trend for PixarBio's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PixarBio Other Long-Term Liabilities Chart

PixarBio Annual Data

Trend

Dec14

Dec15

Other Long-Term Liabilities

PixarBio Quarterly Data
	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16
Other Long-Term Liabilities	Get a 7-Day Free Trial					-	-	-	-	-

PixarBio Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

PixarBio Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of PixarBio's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

PixarBio (PixarBio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PixarBio Corp (GREY:PXRB) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Boston Avenue, Suite 1875, Medford, MA, USA, 02155

Website

https://www.pixarbio.com

PixarBio Corp is a specialty pharmaceutical company focused on preclinical and clinical commercial development of therapeutic drug delivery systems for post-operative pain. The company's lead clinical candidate, NeuroRelease is a non-opioid / non-opiate preclinical stage product intended for the treatment of surgical pain, with planned future indications for chronic pain. NeuroRelease blocks nociceptive and neuropathic pain signals arising from temperature and pressure stimuli without affecting motor function, which is intended to allow for effective treatment without delaying post-surgical physical therapy.